Psychosomatic Fever Mimicking Lupus Flare in a Young Male with Cutaneous SLE and Severe Hyponatremia: a Rare and Challenging Diagnostic Scenario
Abstract
Fever in systemic lupus erythematosus (SLE) may result from disease activity, infection, or non-inflammatory conditions, making the diagnostic process challenging. We report a case of a man in his twenties with a history of cutaneous lupus who presented with persistent fever, fatigue, vomiting, and active skin lesions. Laboratory findings revealed mild anemia, vitamin D deficiency, and positive anti-ribosomal P and anti-Ro60 antibodies without evidence of major organ involvement. The patient received immunosuppressive therapy and metabolic correction; however, the fever persisted. Psychiatric evaluation revealed a depressive episode, and following the initiation of maprotiline therapy, the fever completely resolved. This case highlights the importance of considering psychogenic fever in patients with SLE in order to avoid overtreatment and underscores the need for a multidisciplinary approach.
Keywords
Full Text:
PDFReferences
Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480–91. 2. Doria A, Zen M, Canova M, Bettio S, Bassi N, Nalotto L, et al. SLE diagnosis and treatment: when early is early. Autoimmun Rev. 2013;12(1):55–60. 3. Olivieri G, Ceccarelli F, Perricone C, Ciccacci C, Pirone C, Natalucci F, et al. Fever in systemic lupus erythematosus: associated clinical features and genetic factors. Clin Exp Rheumatol. 2022;40(11):2141–6. 4. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–9. 5. Hanly JG. Neuropsychiatric lupus. Rheum Dis Clin N Am. 2014;40(1):15–33. 6. Oka T. Psychogenic fever: a psychosomatic disease caused by stress. Temperature. 2015;2(3):368–78. 7. Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. JAMA Dermatol. 2013;149(3):284–92. 8. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–21. 9. Kuhn A, Landmann A, Bonsmann G. Cutaneous lupus erythematosus: update of therapeutic options part I. J Am Acad Dermatol. 2016;74(5):943–59. 10. King N. Advances in the diagnosis and management of systemic lupus erythematosus: a review of recent clinical guidelines. Int J Clin Rheumatol. 2024;19(9):313–5. 11. Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med. 2023;74:339–52. 12. Bertsias GK, Ioannidis JPA, Aringer M, Bollen E, Bombardieri S, Bruce IN, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations. Ann Rheum Dis. 2010;69(12):2074–82.
Refbacks
- There are currently no refbacks.


